Advertisement

Fetal Alcohol Exposure Increases Susceptibility to Carcinogenesis and Promotes Tumor Progression in Prostate Gland

  • Dipak K. Sarkar
Conference paper
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 815)

Abstract

The idea that exposure to adverse environmental conditions and lifestyle choices during pregnancy can result in fetal programming that underlies disease susceptibility in adulthood is now widely accepted. Fetal alcohol exposed offspring displays many behavioral and physiological abnormalities including neuroendocrine–immune functions, which often carry over into their adult life. Since the neuroendocrine–immune system plays an important role in controlling tumor surveillance, fetal alcohol exposed offspring can be vulnerable to develop cancer. Animal studies have recently showed increased cancer growth and progression in various tissues of fetal alcohol exposed offspring. I will detail in this chapter the recent evidence for increased prostate carcinogenesis in fetal alcohol exposed rats. I will also provide evidence for a role of excessive estrogenization during prostatic development in the increased incidence of prostatic carcinoma in these animals. Furthermore, I will discuss the additional possibility of the involvement of impaired stress regulation and resulting immune incompetence in the increased prostatic neoplasia in the fetal alcohol exposed offspring.

Keywords

Fetal alcohol Prostate cancer Estrogen Beta-endorphin Stress axis Innate immune system 

Notes

Acknowledgment

This work was partly supported by National Institute of Health grants R37AA08757 and R01AA11591. Prostate research works were conducted in our laboratory by Drs. Sengottuvelan Murugan, Changqing Zhang, Sepideh Mojtahedzadeh, and Nadka Boyadjieva.

References

  1. 1.
    Adami HO, McLaughlin JK, Hsing AW, Wolk A, Ekbom A, Holmberg L, Persson I (1992) Alcoholism and cancer risk: a population-based cohort study. Cancer Causes Control 3(5):419–425PubMedCrossRefGoogle Scholar
  2. 2.
    Adler UC, Marques AH, Calil HM (2008) Inflammatory aspects of depression. Inflamm Allergy Drug Targets 7(1):19–23PubMedCrossRefGoogle Scholar
  3. 3.
    Akil H, Watson SJ, Young E et al (1984) Endogenous opioids: biology and function. Annu Rev Neurosci 7:223–255PubMedCrossRefGoogle Scholar
  4. 4.
    Arjona A, Boyadjieva N, Kuhn P, Sarkar DK (2006) Fetal ethanol exposure disrupts the daily rhythms of splenic granzyme B, IFN-gamma, and NK cell cytotoxicity in adulthood. Alcohol Clin Exp Res 30(6):1039–1104PubMedCrossRefGoogle Scholar
  5. 5.
    Azouz EM, Kavianian G, Der Kaloustian VM (1993) Fetal alcohol syndrome and bilateral tibial exostoses. A case report. Pediatr Radiol 23(8):615–616PubMedCrossRefGoogle Scholar
  6. 6.
    Bagnardi V, Blangiardo M, La Vecchia C, Corrao G (2001) A meta-analysis of alcohol drinking and cancer risk. Br J Cancer 85(11):1700–1705PubMedCentralPubMedCrossRefGoogle Scholar
  7. 7.
    Battisti L, Degani D, Rugolotto S, Borgna-Pignatti C (1993) Fetal alcohol syndrome and malignant disease: a case report. Am J Pediatr Hematol Oncol 5(1):136–137CrossRefGoogle Scholar
  8. 8.
    Becker H, Zaunschirm A, Muntean W, Domej W (1982) Fetal alcohol syndrome and malignant tumors. Wien Klin Wochenschr 94(14):364–365PubMedGoogle Scholar
  9. 9.
    Ben-Eliyahu S (2013) The promotion of tumor metastasis by surgery and stress: immunological basis and implications for psychoneuroimmunology. Brain Behav Immun 17(Suppl 1):S27–S36Google Scholar
  10. 10.
    Bonkhoff H, Berges R (2009) The evolving role of oestrogens and their receptors in the development and progression of prostate cancer. Eur Urol 55(3):533–542PubMedCrossRefGoogle Scholar
  11. 11.
    Bostrom B, Nesbit ME Jr (1983) Hodgkin disease in a child with fetal alcohol-hydantoin syndrome. J Pediatr 103(5):760–762PubMedCrossRefGoogle Scholar
  12. 12.
    Boyadjieva N, Advis JP, Sarkar DK (2006) Role of beta-endorphin, corticotropin-releasing hormone and autonomic nervous system in mediation of the effect of chronic ethanol on natural killer cell cytolytic activity. Alcohol Clin Exp Res 30(10):1761–1767PubMedCrossRefGoogle Scholar
  13. 13.
    Boyadjieva NI, Ortigüela M, Arjona A et al (2009) Beta-endorphin neuronal cell transplant reduces corticotropin releasing hormone hyperresponse to lipopolysaccharide and eliminates natural killer cell functional deficiencies in fetal alcohol exposed rats. Alcohol Clin Exp Res 33(5):931–937PubMedCentralPubMedCrossRefGoogle Scholar
  14. 14.
    Braun MM, Ahlbom A, Floderus B et al (1995) Effect of twinship on incidence of cancer of the testis, breast, and other sites (Sweden). Cancer Causes Control 6(6):519–524PubMedCrossRefGoogle Scholar
  15. 15.
    Breslow RA, Chen CM, Graubard BI, Mukamal KJ (2011) Prospective study of alcohol consumption quantity and frequency and cancer-specific mortality in the US population. Am J Epidemiol 174(9):1044–1053PubMedCentralPubMedCrossRefGoogle Scholar
  16. 16.
    Capuron L, Miller AH (2011) Immune system to brain signaling: neuropsychopharmacological implications. Pharmacol Ther 130(2):226–238PubMedCentralPubMedCrossRefGoogle Scholar
  17. 17.
    Chen CP, Kuhn P, Advis JP, Sarkar DK (2006) Prenatal ethanol exposure alters the expression of period genes governing the circadian function of beta-endorphin neurons in the hypothalamus. J Neurochem 97(4):1026–1033PubMedCrossRefGoogle Scholar
  18. 18.
    Chen WY, Rosner B, Hankinson SE et al (2011) Moderate alcohol consumption during adult life, drinking patterns, and breast cancer risk. JAMA 306(17):1884–1890PubMedCentralPubMedCrossRefGoogle Scholar
  19. 19.
    Coffey DS (2001) Similarities of prostate and breast cancer: evolution, diet, and estrogens. Urology 57(4 Suppl 1):31–38PubMedCrossRefGoogle Scholar
  20. 20.
    Cohen MM Jr (1981) Neoplasia and the fetal alcohol and hydantoin syndromes. Neurobehav Toxicol Teratol 3(2):161–162PubMedGoogle Scholar
  21. 21.
    Crispo A, Talamini R, Gallus S et al (2004) Alcohol and the risk of prostate cancer and benign prostatic hyperplasia. Urology 64(4):717–722PubMedCrossRefGoogle Scholar
  22. 22.
    Cunha GR, Wang YZ, Hayward SW, Risbridger GP (2001) Estrogenic effects on prostatic differentiation and carcinogenesis. Reprod Fertil Dev 13(4):285–296PubMedCrossRefGoogle Scholar
  23. 23.
    Driscoll SG, Taylor SH (1980) Effects of prenatal maternal estrogen on the male urogenital system. Obstet Gynecol 56(5):537–542PubMedGoogle Scholar
  24. 24.
    Gangisetty O, Wynne O, Radl DB, Maglakelidze G, Sarkar DK (2013) Fetal alcohol exposures epigenetically program the growth regulatory mechanism and increase the susceptibility to prolactin-secreting pituitary tumors. Alcohol Clin Exp Res 37:64AGoogle Scholar
  25. 25.
    Giovannucci E, Michaud D (2007) The role of obesity and related metabolic disturbances in cancers of the colon, prostate, and pancreas. Gastroenterology 132(6):2208–2225PubMedCrossRefGoogle Scholar
  26. 26.
    Goldfarb AH, Jamurtas AZ (1997) Beta-endorphin response to exercise. An update. Sports Med 24(1):8–16PubMedCrossRefGoogle Scholar
  27. 27.
    Gong Z, Kristal AR, Schenk JM et al (2009) Alcohol consumption, finasteride, and prostate cancer risk: results from the Prostate Cancer Prevention Trial. Cancer 115(16):3661–3669PubMedCentralPubMedCrossRefGoogle Scholar
  28. 28.
    Gottesfeld Z, Trippe K, Wargovich MJ, Berkowitz AS (1992) Fetal alcohol exposure and adult tumorigenesis. Alcohol 9(6):465–471PubMedCrossRefGoogle Scholar
  29. 29.
    Greene DR, Wheeler TM, Egawa S et al (1991) Relationship between clinical stage and histological zone of origin in early prostate cancer: morphometric analysis. Br J Urol 68(5):499–509PubMedCrossRefGoogle Scholar
  30. 30.
    Hellemans KG, Sliwowska JH, Verma P, Weinberg J (2010) Prenatal alcohol exposure: fetal programming and later life vulnerability to stress, depression and anxiety disorders. Neurosci Biobehav Rev 34(6):791–807PubMedCrossRefGoogle Scholar
  31. 31.
    Higgins SJ, Brooks DE, Fuller FM et al (2007) Steroid hormones and carcinogenesis of the prostate: the role of estrogens. Differentiation 75(9):871–882CrossRefGoogle Scholar
  32. 32.
    Hilakivi-Clarke L, Cabanes A, de Assis S et al (2004) In utero alcohol exposure increases mammary tumorigenesis in rats. Br J Cancer 90(11):2225–2231PubMedCentralPubMedGoogle Scholar
  33. 33.
    Hornstein L, Crowe C, Gruppo R (1977) Adrenal carcinoma in child with history of fetal alcohol syndrome. Lancet 2(8051):1292–1293PubMedCrossRefGoogle Scholar
  34. 34.
    Infante-Rivard C, El-Zein M (2007) Parental alcohol consumption and childhood cancers: a review. J Toxicol Environ Health B Crit Rev 10(1–2):101–129PubMedCrossRefGoogle Scholar
  35. 35.
    Johnson S, Knight R, Marmer DJ, Steele RW (1981) Immune deficiency in fetal alcohol syndrome. Pediatr Res 15(6):908–911PubMedCrossRefGoogle Scholar
  36. 36.
    Kawano H, Masuko S (2007) Beta-endorphin-, adrenocorticotrophic hormone- and neuropeptide y-containing projection fibers from the arcuate hypothalamic nucleus make synaptic contacts on to nucleus preopticus medianus neurons projecting to the paraventricular hypothalamic nucleus in the rat. Neuroscience 98(3):555–565CrossRefGoogle Scholar
  37. 37.
    Khan A, Bader JL, Hoy GR, Sinks LF (1979) Hepatoblastoma in child with fetal alcohol syndrome. Lancet 1(8131):1403–1404PubMedCrossRefGoogle Scholar
  38. 38.
    Kiess W, Linderkamp O, Hadorn HB, Haas R (1984) Fetal alcohol syndrome and malignant disease. Eur J Pediatr 143(2):160–161PubMedCrossRefGoogle Scholar
  39. 39.
    Kiley VA, Lazerson J (1986) Agenesis of the corpus callosum and neural crest tumors. Pediatr Hematol Oncol 3(2):179–182PubMedCrossRefGoogle Scholar
  40. 40.
    Kinney H, Faix R, Brazy J (1980) The fetal alcohol syndrome and neuroblastoma. Pediatrics 66(1):130–132PubMedGoogle Scholar
  41. 41.
    Lau KM, Leav I, Ho SM (1998) Rat estrogen receptor-α and -β, and progesterone receptor mRNA expression in various prostatic lobes and microdissected normal and dysplastic epithelial tissues of the Noble rats. Endocrinology 139(1):424–427PubMedGoogle Scholar
  42. 42.
    Lee S, Schmidt D, Tilders F, Rivier C (2000) Increased activity of the hypothalamic-pituitary adrenal axis of rats exposed to alcohol in utero: role of altered pituitary and hypothalamic function. Mol Cell Neurosci 16(4):515–528PubMedCrossRefGoogle Scholar
  43. 43.
    Maskarinec G, Morimoto Y, Takata Y et al (2006) Alcohol and dietary fibre intakes affect circulating sex hormones among premenopausal women. Public Health Nutr 9(7):875–881PubMedCrossRefGoogle Scholar
  44. 44.
    Mongraw-Chaffin ML, Cohn BA, Anglemyer AT et al (2009) Maternal smoking, alcohol, and coffee use during pregnancy and son’s risk of testicular cancer. Alcohol 43(3):241–245PubMedCentralPubMedCrossRefGoogle Scholar
  45. 45.
    Moreno-Smith M, Lutgendorf SK, Sood AK (2010) Impact of stress on cancer metastasis. Future Oncol 6(12):1863–1881PubMedCentralPubMedCrossRefGoogle Scholar
  46. 46.
    Murugan S, Zhang C, Mojtahedzadeh S, Sarkar DK (2013) Alcohol exposure in utero increases susceptibility to prostate tumorigenesis in rat offspring. Alcohol Clin Exp Res 37:1901–1909. doi: 10.1111/acer.12171 PubMedCrossRefGoogle Scholar
  47. 47.
    Narod SA (2011) Alcohol and risk of breast cancer. JAMA 306(17):1920–1921PubMedCrossRefGoogle Scholar
  48. 48.
    Naslund MJ, Coffey DS (1986) The differential effects of neonatal androgen, estrogen and progesterone on adult rat prostate growth. J Urol 136(5):1136–1140PubMedGoogle Scholar
  49. 49.
    Nicholson TM, Ricke WA (2011) Androgens and estrogens in benign prostatic hyperplasia: past, present and future. Differentiation 82(4–5):184–199PubMedCentralPubMedCrossRefGoogle Scholar
  50. 50.
    Padgett DA, Glaser R (2003) How stress influences the immune response. Trends Immunol 24:444–448PubMedCrossRefGoogle Scholar
  51. 51.
    Plotsky PM, Thrivikraman KV, Meaney MJ (1993) Central and feedback regulation of hypothalamic corticotropin-releasing factor secretion. Ciba Found Symp 172:59–75PubMedGoogle Scholar
  52. 52.
    Polanco TA, Crismale-Gann C, Reuhl KR et al (2010) Fetal alcohol exposure increases mammary tumor susceptibility and alters tumor phenotype in rats. Alcohol Clin Exp Res 34(11):1879–1887PubMedCrossRefGoogle Scholar
  53. 53.
    Polanco TA, Crismale-Gann C, Cohick WS (2011) Alcohol exposure in utero leads to enhanced prepubertal mammary development and alterations in mammary IGF and estradiol systems. Horm Cancer 2(4):239–248PubMedCrossRefGoogle Scholar
  54. 54.
    Price D (1963) Comparative aspects of development and structure in the prostate. In: Vollmer EP (ed) Biology of the prostate and related tissues. National Cancer Institute, Washington DC, pp 1–27Google Scholar
  55. 55.
    Prins GS (1997) Developmental estrogenization of the prostate gland. In: Naz RK (ed) Prostate: basic and clinical aspects. CRC Press, Boca Raton, pp 247–265Google Scholar
  56. 56.
    Prins GS, Birch L (1995) The developmental pattern of androgen receptor expression in rat prostate lobes is altered after neonatal exposure to estrogen. Endocrinology 136(3):1303–1314PubMedGoogle Scholar
  57. 57.
    Prins GS, Putz O (2008) Molecular signaling pathways that regulate prostate gland development. Differentiation 76(6):641–659PubMedCentralPubMedCrossRefGoogle Scholar
  58. 58.
    Prins GS, Marmer M, Woodham C et al (1998) Estrogen receptor-β messenger ribonucleic acid ontogeny in the prostate of normal and neonatally estrogenized rats. Endocrinology 139(3):874–883PubMedGoogle Scholar
  59. 59.
    Prins GS, Birch L, Habermann H et al (2001) Influence of neonatal estrogens on rat prostate development. Reprod Fertil Dev 13(4):241–252PubMedCrossRefGoogle Scholar
  60. 60.
    Putz O, Prins GS (2002) Prostate gland development and estrogenic imprinting. In: Burnstein KL (ed) Steroid hormones and cell cycle regulation. Kluwer Academic Publishers, Boston, MA, pp 73–89CrossRefGoogle Scholar
  61. 61.
    Pylkkanen L, Makela S, Valve E et al (1993) Prostatic dysplasia associated with increased expression of C-MYC in neonatally estrogenized mice. J Urol 149(6):1593–1601PubMedGoogle Scholar
  62. 62.
    Rajfer J, Coffey DS (1978) Sex steroid imprinting of the immature prostate. Invest Urol 16(3):186–190PubMedGoogle Scholar
  63. 63.
    Ramilo J, Harris VJ (1979) Neuroblastoma in a child with the hydantoin and fetal alcohol syndrome. The radiographic features. Br J Radiol 52(624):993–935PubMedCrossRefGoogle Scholar
  64. 64.
    Rehm J, Baliunas D, Borges GL et al (2010) The relation between different dimensions of alcohol consumption and burden of disease: an overview. Addiction 105(5):817–843PubMedCentralPubMedCrossRefGoogle Scholar
  65. 65.
    Ricke WA, McPherson SJ, Bianco JJ et al (2008) Prostatic hormonal carcinogenesis is mediated by in situ estrogen production and estrogen receptor alpha signaling. FASEB J 22(5):1512–1520PubMedCrossRefGoogle Scholar
  66. 66.
    Rothman KJ (1980) The proportion of cancer attributable to alcohol consumption. Prev Med 9(2):174–179PubMedCrossRefGoogle Scholar
  67. 67.
    Santti R, Newbold RR, Makela S et al (1994) Developmental estrogenization and prostatic neoplasia. Prostate 24(2):67–78PubMedCrossRefGoogle Scholar
  68. 68.
    Sarkar DK, Kuhn P, Marano J et al (2007) Alcohol exposure during the developmental period induces beta-endorphin neuronal death and causes alteration in the opioid control of stress axis function. Endocrinology 148(6):2828–2834PubMedCrossRefGoogle Scholar
  69. 69.
    Sarkar DK, Boyadjieva NI, Chen CP et al (2008) Cyclic adenosine monophosphate differentiated beta-endorphin neurons promote immune function and prevent prostate cancer growth. Proc Natl Acad Sci U S A 105(26):9105–9110PubMedCentralPubMedCrossRefGoogle Scholar
  70. 70.
    Sarkar DK, Zhang C, Murugan S (2011) Transplantation of β-endorphin neurons into the hypothalamus promotes immune function and restricts the growth and metastasis of mammary carcinoma. Cancer Res 71(19):6282–6291PubMedCentralPubMedCrossRefGoogle Scholar
  71. 71.
    Sarkar DK, Murugan S, Zhang C, Boyadjieva N (2012) Regulation of cancer progression by β- endorphin neuron. Cancer Res 72(4):836–480PubMedCentralPubMedCrossRefGoogle Scholar
  72. 72.
    Seeler RA, Israel JN, Royal JE, Kaye CI, Rao S, Abulaban M (1979) Ganglioneuroblastoma and fetal hydantoin-alcohol syndromes. Pediatrics 63(4):524–527PubMedGoogle Scholar
  73. 73.
    Severson RK, Buckley JD, Woods WG et al (1993) Cigarette smoking and alcohol consumption by parents of children with acute myeloid leukemia: an analysis within morphological subgroups—a report from the Children’s Cancer Group. Cancer Epidemiol Biomarkers Prev 2(5):433–439PubMedGoogle Scholar
  74. 74.
    Singletary KW, Frey RS, Yan W (2001) Effect of ethanol on proliferation and estrogen receptor-alpha expression in human breast cancer cells. Cancer Lett 165(2):131–137PubMedCrossRefGoogle Scholar
  75. 75.
    Steinhausen HC (1995) Children of alcoholic parents. A review. Eur Child Adolesc Psychiatry 4(3):143–152PubMedCrossRefGoogle Scholar
  76. 76.
    Taylor AN, Ben-Eliyahu S, Yirmiya R et al (1993) Action of alcohol on immunity and neoplasia in fetal alcohol exposed and adult rats. Alcohol Alcohol Suppl 2:69–74PubMedGoogle Scholar
  77. 77.
    Thygesen LC, Albertsen K, Johansen C, Grønbaek M (2005) Cancer incidence among Danish brewery workers. Int J Cancer 116(5):774–778PubMedCrossRefGoogle Scholar
  78. 78.
    Tønnesen H, Moller H, Andersen JR et al (1994) Cancer morbidity in alcohol abusers. Br J Cancer 69(2):327–332PubMedCentralPubMedCrossRefGoogle Scholar
  79. 79.
    Velicer CM, Kristal A, White E (2006) Alcohol use and the risk of prostate cancer: results from the VITAL cohort study. Nutr Cancer 56(1):50–56PubMedCrossRefGoogle Scholar
  80. 80.
    Winstanley MH, Pratt IS, Chapman K (2011) Alcohol and cancer: a position statement from Cancer Council Australia. Med J Aust 194(9):479–482PubMedGoogle Scholar
  81. 81.
    Witek-Janusek L, Gabram S, Mathews HL (2007) Psychologic stress, reduced NK cell activity, and cytokine dysregulation in women experiencing diagnostic breast biopsy. Psychoneuroendocrinology 32(1):22–35PubMedCentralPubMedCrossRefGoogle Scholar
  82. 82.
    Yuen MT, Leung LK, Wang J et al (2005) Enhanced induction of prostatic dysplasia and carcinoma in Noble rat model by combination of neonatal estrogen exposure and hormonal treatments at adulthood. Int J Oncol 27(6):1685–1695PubMedGoogle Scholar
  83. 83.
    Zaunschirm A, Muntean W (1984) Fetal alcohol syndrome and malignant disease. Eur J Pediatr 141(4):256PubMedCrossRefGoogle Scholar
  84. 84.
    Zhang C, Sarkar DK (2012) β-endorphin neuron transplantation: a possible novel therapy for cancer prevention. Oncoimmunology 1(4):552–554PubMedCentralPubMedCrossRefGoogle Scholar
  85. 85.
    Zhang X, Sliwowska JH, Weinberg J (2005) Prenatal alcohol exposure and fetal programming effects on neuroendocrine and immune function. Exp Biol Med (Maywood) 230(6):376–388Google Scholar
  86. 86.
    Zhang C, Boyadjieva N, Ortiguela M et al (2012) Fetal alcohol exposure increases tumor colonization in the lung: role of hypothalamic beta-endorphin. Alcohol Clin Exp Res 36:198ACrossRefGoogle Scholar
  87. 87.
    Zondek T, Mansfield MD, Attree SL, Zondek LH (1986) Hormone levels in the fetal and neonatal prostate. Acta Endocr 112(3):447–456PubMedGoogle Scholar

Copyright information

© Springer International Publishing Switzerland 2015

Authors and Affiliations

  1. 1.Endocrinology Program and Department of Animal Sciences, RutgersThe State University of New JerseyNew BrunswickUSA

Personalised recommendations